Current Document Type: HighlightsVideoPage Tiffany Richards, PhD, ANP-BC, AOCNP, on Responses to a GPRC5D-Targeted CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma - JADPRO

Watch More Highlights

Tiffany Richards, PhD, ANP-BC, AOCNP®, of The University of Texas MD Anderson Cancer Center, reviews updated efficacy and safety data for BMS-986393 (CC‑95266), a GPRC5D-targeted autologous chimeric antigen receptor (CAR) T-cell therapy in patients with relapsed/refractory multiple myeloma. This first-in-human study showed a manageable safety profile, along with deep and durable responses, including minimal residual disease negativity (Abstract 219).

Copyright © 2010-2022 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.